The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Novel functions for NFκB: inhibition of bone formation
Open accessAbstract
NFκB is a family of transcription factors involved in immunity and the normal functioning of many tissues. It has been well studied in osteoclasts, and new data indicate an important role for NFκB in the negative regulation of bone formation. In this article, we discuss how NFκB activation affects osteoblast function and bone formation. In particular, we describe how reduced NFκB activity in osteoblasts results in an increase in bone formation via enhanced c-Jun N-terminal kinase (JNK) activity, which regulates FOSL1 (also known as Fra1) expression. Furthermore, we discuss how estrogen and NFκB crosstalk in osteoblasts acts to oppositely regulate bone formation. Future NFκB-targeting treatments for osteoporosis, rheumatoid arthritis and other inflammatory bone diseases could lead to increased bone formation concurrent with decreased bone resorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 1×
“Receptor activator of nuclear factor κB ligand (RANKL; also known as TNF ligand superfamily, member 11) is an essential cytokine in osteoclastogenesis, along with macrophage colony stimulating factor (M-CSF)”
BackgroundMissing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1×
“133" language="eng" publish="issue" relation="no"> Introduction The transcription factor NFκB represents a family of five mammalian proteins (c-Rel, RelA, RelB, NFκB1 and NFκB2) that regulate a wide variety of genes involved in immune and inflammatory responses, among many other functions”
BackgroundPathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779 · cited 1×
“Implications for therapy Currently, many drugs used in the treatment of osteoporosis are bone resorption inhibitors”
BackgroundUbiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
Estrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990 · cited 1×
“Interestingly, these cytokines are produced by macrophages, lymphocytes, osteoblasts and bone marrow stromal cell”
BackgroundInduction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., & Franzoso, G. (2001) · Nature · doi:10.1038/35104560 · Cited by 732
Cited by
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Chang, J., Liu, F., Lee, M., Wu, B., Ting, K., Zara, J. N., Soo, C., Al Hezaimi, K., Zou, W., Chen, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300532110 · Cited by 329
Self-citationEstrogen receptors alpha and beta in bone
Khalid, A. B., & Krum, S. A. (2016) · Bone · doi:10.1016/j.bone.2016.03.016 · Cited by 291
Self-citationXu, J.-F., Yang, G.-H., Pan, X.-H., Zhang, S.-J., Zhao, C., Qiu, B.-S., Gu, H.-F., Hong, J.-F., Cao, L., Chen, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114627 · Cited by 235
High-density lipoprotein (HDL) metabolism and bone mass
Papachristou, N. I., Blair, H. C., Kypreos, K. E., & Papachristou, D. J. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0657 · Cited by 94
Metadata
- Authors
- Krum, S. A., Chang, J., Miranda-Carboni, G., & Wang, C.-Y.
- Venue
- Nature Reviews Rheumatology
- Published
- 2010-08-10
- Volume
- 6
- Issue
- 10
- Pages
- 607-611
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2004316687
- Cited by
- 159
- References
- 6
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel functions for NFκB: inhibition of bone formation. https://app.cochat.ai/papers/10.1038/nrrheum.2010.133
- The paper
- Krum, S. A., Chang, J., Miranda-Carboni, G., & Wang, C.-Y. (2010). Novel functions for NFκB: inhibition of bone formation. Nature Reviews Rheumatology. https://doi.org/10.1038/nrrheum.2010.133
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.